Pierce Protease and Phosphatase Inhibitor and 1 more item

The University of Nebraska, acting through the Board of Regents, awarded a purchase order (PO 4800184307) to Life Technologies Corporation on March 5, 2026, for the procurement of two specialized laboratory reagents. The contract, valued at $691.41, covers Pierce Protease and Phosphatase Inhibitor (material number A32961, $242.11) and Amplex Red Hydrogen Peroxide/Peroxidase (material number A22188, $449.30). Delivery is scheduled for March 9, 2026, to the University of Nebraska Medical Center's Shipping and Receiving department in Omaha, Nebraska, with freight prepaid on a Free on Board (F.O.B.) destination basis. Payment terms are Net 30 days.

Life Technologies Corporation, located in Pittsburgh, Pennsylvania, serves as the prime contractor for this procurement. The purchase order requires vendor acknowledgment within ten days and mandates that the purchase order number appear on all packages, invoices, and accompanying documentation. These laboratory reagents are consumable materials utilized in biochemical research and diagnostic applications at the University of Nebraska Medical Center. The brief performance period reflects the straightforward nature of a goods procurement requiring minimal ancillary services beyond delivery and standard vendor compliance obligations.